(C) SiCDK6 suppressed bladder cancer cell growth. (D) SiCDK6 reduced the colony formation rate in both cell GSK690693 in vivo lines (representative wells were presented). (E) SiCDK6 induced G1-phase arrest in both cell lines (representative histograms were presented). (F) SiCDK6 yield an inhibitory effect on invasion and migration in both cell lines (×200) (*P < 0.05). Restoration of CDK6 PF-6463922 expression partially rescues miR-320c-induced suppression of tumorous behavior We had verified

that over-expression of miR-320c could induce G1-phase arrest, suppression of cell invasion and migration before and we wondered whether forced CDK6 expression could abrogate the cell cycle arrest and promote cell motility by miR-320c. In parallel, co-transfection of pCDK6 was applied to attenuate the CDK6 expression inhibition by miR-320c (Figure 7A). Forced CDK6 expression partially, but significantly, promoted cell proliferation and motility (Figure 7B, C). We also observed a significant decrease in the percentage of cells in the G1/G0 phase and an increase in the G2/M phase, which indicating that co-transfection of pCDK6 and miR-320c could attenuate the G1-phase arrest by miR-320c (Figure 7D). Thus, we confirmed that CDK6 was selleck chemicals llc a key mediator of tumor suppression function

of miR-320c in bladder cancer. Figure 7 Forced expression of CDK6 partly rescued miR-320c-dependent suppression of tumorous behavior. The T24 cells were co-transfected with either miR-320c mimics or NC oligos with pTarget-CDK6 or empty pTarget vector. (A) The expression of CDK6 or GAPDH was detected by Western blot analysis. (B) Forced CDK6 expression partly attenuated the inhibitory effect of miR-320c Nintedanib (BIBF 1120) on the colony formation rate. (C) Co-transfection of pCDK6 partially rescued miR-320c-induced inhibitory effect on cell invasion and migration (×200). (D) Forced expression

of CDK6 significantly abrogated cell cycle arrest effect of miR-320c (*P < 0.05). Discussion During the past decades, effective targeted therapies of bladder cancer contributing to improved prognosis were the highlight of researches [27]. In recent years, a growing number of researches illustrated that abnormal expression of miRNAs was considered to be a key regulator in carcinogenesis [28,29]. Moreover, aberrant expression profiles of miRNA in cancer detected by microarray analysis provided deeper insights into the molecular passages of carcinogenesis [17,18,30]. A previous systematic review summarized the dysfunction of miRNAs in bladder cancer, which would help to establish a mature system in diagnosis and therapy using miRNAs in the future [14]. However, limited studies were focused on the regulative functional role of miRNAs in bladder cancer. The impact of specific miRNAs in bladder was still poorly understood. Thereafter, our institution performed some researches to elucidate the potential relationship between bladder cancer and miRNAs [31,32].